Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvet

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Journal of Medical Economics|July 3, 2026
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysisBelén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, et al.
Endoscopy International Open|March 11, 2024
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trialSalvador Machlab, Eva Martínez-Bauer, Pilar López, et al.
Helicobacter|August 3, 2007
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleedingJavier P Gisbert, Xavier Calvet, Faust Feu, et al.
Journal of Crohn'S & Colitis|April 15, 2014
Risk of colectomy in patients with ulcerative colitis under thiopurine treatmentAlex Cañas-Ventura, Lucia Márquez, Elena Ricart, et al.
Journal of Clinical Gastroenterology|December 9, 2014
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapyCarlos Castaño-Milla, María Chaparro, Cristina Saro, et al.
The American Journal of Gastroenterology|December 23, 2008
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter studyCarme Loras, Cristina Saro, Ferràn Gonzalez-Huix, et al.
Journal of Clinical Gastroenterology|June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patientsJavier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Revista Espanola De Enfermedades Digestivas|April 23, 2026
Prevalence, incidence and mortality of pediatric inflammatory bowel disease in Catalonia (EPIBDCat)Eduard Brunet, Inés Loverdos, Emili Vela, et al.
Digestive Diseases and Sciences|December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose EscalationCarlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Journal of Medical Economics|July 3, 2026
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysisBelén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, et al.
Endoscopy International Open|March 11, 2024
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trialSalvador Machlab, Eva Martínez-Bauer, Pilar López, et al.
Helicobacter|August 3, 2007
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleedingJavier P Gisbert, Xavier Calvet, Faust Feu, et al.
Journal of Crohn'S & Colitis|April 15, 2014
Risk of colectomy in patients with ulcerative colitis under thiopurine treatmentAlex Cañas-Ventura, Lucia Márquez, Elena Ricart, et al.
Journal of Clinical Gastroenterology|December 9, 2014
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapyCarlos Castaño-Milla, María Chaparro, Cristina Saro, et al.
The American Journal of Gastroenterology|December 23, 2008
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter studyCarme Loras, Cristina Saro, Ferràn Gonzalez-Huix, et al.
Journal of Clinical Gastroenterology|June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patientsJavier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Revista Espanola De Enfermedades Digestivas|April 23, 2026
Prevalence, incidence and mortality of pediatric inflammatory bowel disease in Catalonia (EPIBDCat)Eduard Brunet, Inés Loverdos, Emili Vela, et al.
Digestive Diseases and Sciences|December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose EscalationCarlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
Pageof 23